Rôle de l'herpèsvirus humain de type 6 dans le ... - Epublications

77, 105-114.
Pradeau, K., Bordessoule, D., Szelag, J. C., Rolle, F., Ferrat, P., Le Meur, Y., Turlure, P.,
Denis, F. & Ranger-Rogez, S. (2006a). A reverse transcription-nested PCR assay for
HHV-6 mRNA early transcript detection after transplantation. J Virol Methods 134, 41-
47.
Pradeau, K., Couty, L., Szelag, J. C., Turlure, P., Rolle, F., Ferrat, P., Bordessoule, D., Le
Meur, Y., Denis, F. & Ranger-Rogez, S. (2006b). Multiplex real-time PCR assay for
simultaneous quantitation of human cytomegalovirus and herpesvirus-6 in
polymorphonuclear and mononuclear cells of transplant recipients. J Virol Methods 132,
77-84.
Qavi, H. B., Green, M. T., Lewis, D. E., Hollinger, F. B., Pearson, G. & Ablashi, D. V.
(1995). HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the
absence of human cytomegalovirus. Invest Ophthalmol Vis Sci 36, 2040-2047.
Raaphorst, F. M., van Kemenade, F. J., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P.,
Otte, A. P. & Meijer, C. J. (2000). Coexpression of BMI-1 and EZH2 polycomb group
genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 157, 709-715.
Rajewsky, K. (1996). Clonal selection and learning in the antibody system. Nature 381, 751-
758.
Ranger, S., Patillaud, S., Denis, F., Himmich, A., Sangare, A., M'Boup, S., Itoua-N'Gaporo,
A., Prince-David, M., Chout, R., Cevallos, R. & et al. (1991). Seroepidemiology of
human herpesvirus-6 in pregnant women from different parts of the world. J Med Virol
34, 194-198.
Rassidakis, G. Z., Medeiros, L. J., McDonnell, T. J., Viviani, S., Bonfante, V., Nadali, G.,
Vassilakopoulos, T. P., Giardini, R., Chilosi, M., Kittas, C., Gianni, A. M.,
Bonadonna, G., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & Sarris, A. H. (2002).
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation
with clinical outcome. Clin Cancer Res 8, 488-493.
Razonable, R. R., Fanning, C., Brown, R. A., Espy, M. J., Rivero, A., Wilson, J., Kremers,
W., Smith, T. F. & Paya, C. V. (2002). Selective reactivation of human herpesvirus 6
variant a occurs in critically ill immunocompetent hosts. J Infect Dis 185, 110-113.
Razzaque, A. (1990). Oncogenic potential of human herpesvirus-6 DNA. Oncogene 5, 1365-
1370.
Razzaque, A., Williams, O., Wang, J. & Rhim, J. S. (1993). Neoplastic transformation of
immortalized human epidermal keratinocytes by two HHV-6 DNA clones. Virology 195,
113-120.
Re, D., Muschen, M., Ahmadi, T., Wickenhauser, C., Staratschek-Jox, A., Holtick, U.,
Diehl, V. & Wolf, J. (2001). Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg
cells. Cancer Res 61, 2080-2084.
Re, D., Thomas, R. K., Behringer, K. & Diehl, V. (2005a). From Hodgkin disease to Hodgkin
lymphoma: biologic insights and therapeutic potential. Blood 105, 4553-4560.
Re, D., Thomas, R. K., Zander, T. & Diehl, V. (2005b). Problems and promises of targeted
therapy for Hodgkin's lymphoma. Nat Clin Pract Oncol 2, 2-3.
Rehwald, U., Schulz, H., Reiser, M., Sieber, M., Staak, J. O., Morschhauser, F., Driessen,
C., Rudiger, T., Muller-Hermelink, K., Diehl, V. & Engert, A. (2003). Treatment of
relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective
and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study
Group. Blood 101, 420-424.
175